Trade FHTX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Foghorn Therapeutics Inc. (FHTX) is trading at US$6.01, down 3.38% today as of Aug 28, 12:39 EDT. The company has a market capitalisation of US$419.85M. Over the past 52 weeks, FHTX has traded between US$3.27 and US$7.61. On Syfe you can trade FHTX with $0 commission and add it to your watchlist.
| Previous close | US$6.22 |
|---|---|
| Market cap | US$419.85M |
| 52-week range | US$3.27 – US$7.61 |
| Volume | 432.64K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Foghorn Therapeutics Inc.
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Watertown, MA.
Year: 2020
Foghorn Therapeutics Inc. (FHTX) stock is trading at US$6.01, -3.38% from the previous close of US$6.22.
The market cap for Foghorn Therapeutics Inc. (FHTX) stock is approximately US$419.85M.
The 52-week high for Foghorn Therapeutics Inc. (FHTX) stock is US$7.61.
The 52-week low for Foghorn Therapeutics Inc. (FHTX) stock is US$3.27.
Foghorn Therapeutics Inc. (FHTX) does not currently pay a dividend.
Stay on top of FHTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
